Calcium Supplements: Benefits, Forms, Dosing, and Safety

Table of Contents

• Overview
• Forms and Bioavailability
• Evidence for Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Dietary Sources
• References

Overview

Calcium is the most abundant mineral in the human body. Approximately 99% of the body's calcium is stored in bones and teeth as calcium hydroxyapatite, where it provides structural rigidity. The remaining 1% circulates in blood, extracellular fluid, muscle, and other tissues, mediating vascular contraction and dilation, muscle contraction, nerve transmission, blood clotting, and hormonal secretion [1][2][3].

At birth, the body contains approximately 26–30 g of calcium. This rises to about 1,200 g in women and 1,400 g in men by adulthood [1]. In women, calcium levels begin declining after menopause due to estrogen-mediated increases in bone resorption. On average, women lose approximately 1% of their bone mineral density (BMD) per year after menopause [1][4]. About 30% of postmenopausal women in the United States and Europe have osteoporosis, and at least 40% of those develop at least one fragility fracture [4].

Calcium deficiency is common. Analysis of 2007–2010 NHANES data found that 49% of children aged 4–18 and 39% of all individuals aged 4 and older consume less than the Estimated Average Requirement for calcium from foods and supplements [1][5]. Average daily intakes from foods and beverages are 1,083 mg for men aged 20 and older and only 842 mg for women [5]. Inadequacy rates are particularly high among non-Hispanic Blacks and non-Hispanic Asians (47–48%), compared to Hispanics (30%) and non-Hispanic Whites (24%) [6]. Adults in households earning less than $20,000 per year have an 11.6% higher risk of inadequate intakes [7].

Calcium is absorbed in the small intestine via two pathways: active transport (vitamin D-dependent, dominant at low intakes, mediated by the TRPV6 channel) and passive paracellular diffusion (dominant at higher intakes) [1][2][3]. An inverse relationship exists between calcium intake and fractional absorption: approximately 45% is absorbed at intakes of 200 mg/day but only 15% at intakes exceeding 2,000 mg/day [1]. Net absorption is as high as 60% in infants, declines to about 25% in adults, and continues to fall with aging [1]. During pregnancy, absorption efficiency increases from approximately 30% to 50–60% due to elevated calcitriol levels, helping meet fetal demands without requiring increased intake [3][8].

Calcium homeostasis is tightly regulated by parathyroid hormone (PTH), calcitriol (active vitamin D), and calcitonin. Serum calcium is maintained within a narrow range of 8.8–10.4 mg/dL (2.2–2.6 mmol/L) [1][9]. Because of this tight homeostatic control, serum calcium levels do not reflect nutritional status. Dual-energy X-ray absorptiometry (DEXA) scanning of bone mineral density is the best assessment of cumulative calcium status over a lifetime [1][2].

Hypocalcemia (serum calcium <8.5 mg/dL) is usually caused by vitamin D or magnesium deficiency, impaired PTH production, bisphosphonate use, or critical illness [10][11]. Symptoms range from perioral numbness, tingling, and muscle spasms to seizures, cardiac arrhythmias, and, rarely, coma [10][11][12].

Calcium supplements are among the most popular dietary supplements in the United States. However, there is growing evidence that supplemental calcium (as opposed to dietary calcium) may carry risks including kidney stones and cardiovascular events, making the choice of form, dose, and timing important considerations.

Forms and Bioavailability

The form of calcium in a supplement determines three critical factors: elemental calcium content (how much actual calcium per gram of compound), bioavailability (percentage absorbed), and tolerability (particularly gastrointestinal side effects).

Comparison Table

Form	Elemental Ca (%)	Absorption	GI Tolerance	Key Characteristics
Calcium Carbonate	40%	~28–39%	Moderate (constipation, gas)	Most common, least expensive. Requires stomach acid; take with food. Used in antacids (Tums). Poor choice if taking PPIs [2][3][13][14][15].
Calcium Citrate	21%	~30%	Good	Does not require stomach acid. Can be taken without food. Preferred for PPI users and post-bariatric surgery patients. More expensive, larger pills [2][3][13][14][16].
Calcium Citrate Malate	~24%	~35%	Good	Well-absorbed form used in fortified juices. Better absorbed than carbonate or citrate alone in some studies [2][14].
Calcium Phosphate	31–39%	Moderate	Good	Mimics natural bone mineral composition. Used in fortified foods [3][8].
Calcium Hydroxyapatite (MCH/OHC)	Variable	Similar to citrate/carbonate	Good (less constipation)	Derived from cow bone. Contains collagen, magnesium, phosphorus. Does not spike blood calcium as sharply, but increases calcium-phosphate (CVD concern). Roughly equivalent to citrate and carbonate for bone turnover [17].
Calcium Lactate	13%	~31%	Good	Mild taste, suitable for chewable/liquid formulations. Low elemental content [3][14][15].
Calcium Gluconate	9%	~27%	Good	Very low elemental content. Primarily used IV for acute hypocalcemia [3][14][15].
Calcium Acetate	—	~32%	Moderate	Used as a phosphate binder in kidney disease [15].

Absorption data from Sheikh et al., N Engl J Med 1987 [15], Heaney et al., Osteoporos Int 1999 [18], and NIH ODS [1].

Calcium Carbonate

The most common and least expensive form, containing 40% elemental calcium by weight — the highest of any supplement form. Requires stomach acid for solubility, so it should be taken with food. People taking proton-pump inhibitors (PPIs) such as omeprazole may absorb significantly less calcium carbonate — one study showed a 61% reduction in absorption in older women taking 20 mg omeprazole daily [19]. May cause more gastrointestinal side effects (gas, bloating, constipation) than other forms, particularly in older adults with lower stomach acid levels [1].

Calcium Citrate

Contains 21% elemental calcium by weight — roughly half that of calcium carbonate, meaning more pills are needed for the same dose. The key advantage is that it does not require stomach acid for absorption, so it can be taken without food and is preferred for people on PPIs or those who have had bariatric surgery [4]. Even when taken with food, calcium citrate was slightly better absorbed (by about 2%) than calcium carbonate in post-bariatric patients [22]. One study in young men found calcium citrate produced significantly larger increases in serum calcium than calcium carbonate and tricalcium phosphate when taken without food at 1,000 mg [6].

Calcium Citrate Malate

A well-absorbed form commonly used in fortified juices. A study in postmenopausal women showed that 40 mg/day omeprazole did not decrease absorption of calcium from calcium citrate malate in fortified orange juice, unlike its significant effect on calcium carbonate [20].

Calcium Hydroxyapatite

Derived from cow bone, this form contains other minerals (magnesium, phosphorus, potassium) and bone proteins including collagen. It appears roughly equivalent to calcium citrate and calcium carbonate in slowing bone turnover, and may cause less constipation than calcium carbonate. However, it causes higher calcium-phosphate concentrations, which is associated with increased cardiovascular disease risk [17].

Key Principles for Form Selection

For most people with adequate stomach acid: The form may not matter significantly. A study of 8 healthy young men found no statistically significant differences in absorption between calcium carbonate (39%), calcium acetate (32%), calcium lactate (32%), whole milk (31%), calcium citrate (30%), and calcium gluconate (27%) when each provided 500 mg of calcium [15].

For people taking proton pump inhibitors (PPIs): Calcium citrate or calcium citrate malate is strongly preferred. A study among older women found that 20 mg of omeprazole daily caused a 61% reduction in calcium absorption from calcium carbonate supplements [19]. In contrast, calcium citrate malate absorption was not decreased by 40 mg omeprazole daily [20]. Among PPI users, calcium deficiency rates vary by drug: 7.9% for omeprazole, 21.9% for pantoprazole, 21.3% for esomeprazole, and 31% for lansoprazole [21].

For post-bariatric surgery patients: Calcium citrate was found to be slightly better absorbed (by about 2%) than calcium carbonate following gastric bypass or sleeve gastrectomy [22].

For cognitive health in older adults: Some evidence suggests maintaining a calcium-to-magnesium ratio between 1.7 and 2.3 may be important. A study of 250 adults aged 65+ found that reducing the dietary calcium-to-magnesium ratio improved cognition by 9.1% via APOE gene methylation [23].

Plant-based calcium (algae-derived): Products such as AlgaeCal (calcium hydroxide, chloride, sulfate, and carbonate complex from algae) and Aquamin (from red marine algae, primarily calcium carbonate) are marketed as superior forms. However, clinical evidence supporting superior efficacy over standard calcium forms in humans is limited. Two low-quality, company-funded studies of AlgaeCal reported 1.3–4.1% increases in BMD over 6–12 months, but lacked placebo controls and blinding [24][25]. One study of Aquamin showed slightly prolonged PTH suppression compared to calcium carbonate, but the carbonate was taken without food (against recommendations) [26].

How to Read Supplement Labels

The weight of the calcium compound and the weight of elemental calcium are different. Only 40% of the weight of calcium carbonate is calcium, 21% of calcium citrate, and only 9% of calcium gluconate. The Supplement Facts panel should list "elemental calcium" or "Calcium (as calcium carbonate)" with the actual calcium content. If a label reads "Calcium carbonate 500 mg," there is only 200 mg of elemental calcium [1][2][14].

Absorption Considerations

The body absorbs approximately 38% of calcium from a 300 mg supplement dose, but only 28.4% from a 1,000 mg dose — demonstrating the inverse relationship between dose size and absorption efficiency [18]. It is generally recommended to limit individual doses to 500 mg or less and divide larger daily amounts across the day. From foods, absorption is approximately 32% from dairy and lower from plant foods high in phytates or oxalate — only about 5% of calcium from spinach is absorbed [10].

Calcium and Magnesium: Timing Considerations

Products containing both calcium and magnesium are sometimes marketed as improving the absorption of one or both minerals. However, unless magnesium deficiency is present, taking calcium with magnesium does not improve absorption of either mineral, and no specific ratio produces superior absorption [14]. A study in healthy males found that 826 mg of magnesium daily did not affect absorption of calcium taken at 241 or 812 mg daily — though the minerals were taken at different times [27]. Until more research is available, it may be prudent to separate large doses of calcium and magnesium (more than 250 mg each) by at least 2 hours to maximize absorption of both [14].

Correcting magnesium deficiency is critical for calcium status. Magnesium is required for synthesizing parathyroid hormone and converting vitamin D to its active form (calcitriol), both of which are necessary for adequate calcium levels [28].

Evidence for Benefits

Bone Health and Fracture Prevention

Adequate calcium is critical for building and maintaining strong bones, where 99% of the body's calcium resides. Bone is constantly remodeled, with osteoblasts depositing new bone and osteoclasts resorbing old bone. After menopause, declining estrogen shifts this balance toward resorption, accelerating bone loss [1][4].

Bone mineral density in postmenopausal women: Several systematic reviews and meta-analyses have found that calcium supplementation with vitamin D increases BMD in older adults. A systematic review and meta-analysis of 15 RCTs in 78,206 postmenopausal women found that supplementation with calcium and vitamin D increased total BMD as well as BMD at the lumbar spine, arms, and femoral neck [29]. In subgroup analyses, calcium alone had no effect on femoral neck BMD. A 2-year RCT in 500 healthy postmenopausal women found that 900 mg calcium plus 600 IU vitamin D from enriched milk increased BMD at the femoral neck [30]. An earlier systematic review found a positive relationship between calcium and vitamin D supplementation and increased BMD in older males [31].

In young girls: Regular supplementation with 800 mg of calcium and 400 IU of vitamin D daily for six months significantly increased bone density and bone strength (arms and legs) compared to placebo in girls aged 9–13 [32].

Women's Health Initiative (WHI) — 20-year follow-up: This landmark study followed 68,132 postmenopausal women (aged 50–79) for 20 years. Taking 500 mg calcium carbonate and 200 IU vitamin D3 twice daily for seven years produced a 23% reduction in hip fracture among women who began the study at age 60 or older, with the greatest benefit (50% reduction) in women on hormonal therapy. However, women younger than 60 showed a 117% increase in hip fracture — likely because they already had adequate calcium status [33]. Over a median follow-up of 22.3 years, the long-term analysis found no effect on overall CVD risk, but cancer mortality was 7% lower among women who received calcium and vitamin D supplements [34].

Vegan women: A study of 34,542 adults found that vegan women not supplementing with calcium and vitamin D had approximately three times the hip fracture risk of non-vegetarians, while vegan women who supplemented (average 660 mg calcium and 540 IU vitamin D) had no increased risk [35].

Pre/peri-menopausal women: Calcium supplement use was not associated with reduced fracture incidence in pre-menopausal or early peri-menopausal women in a 10-year study, even though it slowed bone mineral density decline [36].

Elderly care facility residents: A study of 7,195 men and women (average age 85) in Australian care facilities found that increasing dietary calcium from 700 mg to 1,152 mg daily through additional dairy foods (not supplements) led to an 11% lower risk of falls after 3 months, a 33% lower risk of all fractures, and a 46% lower risk of hip fractures after 5 months [37].

Meta-analyses on fracture reduction: A meta-analysis of 8 RCTs in 30,970 adults older than 50 found that 500–1,200 mg/day calcium with 400–800 IU/day vitamin D reduced total fractures by 15% and hip fractures by 30% [38]. However, other systematic reviews have shown no benefit, and the USPSTF concluded with moderate certainty that daily doses below 1,000 mg calcium and 400 IU vitamin D do not prevent fractures in postmenopausal women [39][40].

Exercise-induced bone resorption: A study of 40 young women found that 1,000 mg calcium taken one hour before strenuous load-carrying exercise reduced the drop in blood calcium, reduced PTH levels, and reduced a marker of bone turnover. However, some bone turnover is beneficial for building stronger bone, so routine pre-exercise calcium supplementation is not clearly indicated [41].

Cancer

Overall cancer incidence: A large 4-year placebo-controlled study of postmenopausal women found that 1,500 mg calcium and 2,000 IU vitamin D3 daily did not significantly lower overall cancer risk [42]. The WHI trial also found no effect on cancer incidence during the 7-year intervention period [43]. A meta-analysis of 10 RCTs found calcium supplementation did not change total cancer risk [44]. However, one 4-year trial found that 1,400–1,500 mg calcium plus 1,100 IU vitamin D3 reduced cancer incidence by 60% compared to placebo, and calcium alone reduced it by 47% — findings that have been questioned due to study design limitations [45].

Colorectal cancer: The strongest evidence links calcium to colorectal cancer prevention. In a dose-response meta-analysis of 15 prospective cohort studies (n=1,415,597), the risk of colorectal cancer dropped by 8% with each 300 mg/day increase in total calcium intake [46]. A systematic review and meta-analysis of 4 RCTs found that 1,200–2,000 mg calcium daily for 36–60 months reduced recurrent adenomas by 11% [47]. However, the WHI trial found no difference in colorectal cancer rates after calcium and vitamin D supplementation [48]. More concerning, 6–10 years after a supplementation trial, the risk of precancerous polyps was 165% and 281% higher among those who had taken calcium or calcium plus vitamin D supplements, compared to those who took no supplement. The increase was greatest among women and current smokers. Calcium from food was not associated with this risk [49].

Prostate cancer: Observational data suggest a potential link between high calcium intake and prostate cancer risk. In a French cohort study, men in the highest quartile of calcium intake (>1,081 mg/day) had 2.4 times higher prostate cancer risk than those in the lowest quartile (<725 mg/day) — but only calcium from dairy foods was significantly associated with risk [50]. A meta-analysis of 9 cohort studies (n=750,275) found a 2% higher risk per 400 mg/day increment, but nondairy and supplemental calcium were not associated with prostate cancer risk [51]. A placebo-controlled study found 1,200 mg supplemental calcium daily for 4 years did not increase prostate cancer risk [52]. General guidance suggests keeping total calcium intake below 1,500 mg/day [1].

Breast cancer: Evidence is mixed. A meta-analysis of 11 prospective cohort studies (n=872,895 women) found an 8% lower breast cancer risk with the highest calcium intakes [53]. However, the WHI found no difference in invasive breast cancer rates with supplementation [54].

Ovarian cancer: A meta-analysis of 15 studies (n=493,415 women) found that ovarian cancer risk was 20% lower with the highest dietary calcium intakes, though this was not significant when supplemental calcium was included [55].

Cancer mortality: Over 22.3 years of follow-up in the WHI, cancer mortality was 7% lower among women who received calcium and vitamin D supplements compared to placebo [34]. However, other large analyses have found no association between calcium intake and cancer mortality [56][57].

Cardiovascular Disease

The relationship between calcium supplementation and cardiovascular disease (CVD) is one of the most debated topics in nutrition science. The key distinction is between calcium from food (generally safe or beneficial) and calcium from supplements (potentially harmful at high doses).

Heart attack risk: A meta-analysis of pooled clinical trials found a 30% increase in heart attack risk among adults taking calcium supplements compared to those who did not. Calcium from food alone was not associated with increased risk. The risk was greater in those already getting more than 805 mg of calcium from diet [58]. A subsequent analysis confirmed this finding and noted that co-administration of vitamin D did not affect the risk [59]. A large Korean study found that calcium supplementation without vitamin D was associated with a 54% increased risk of major adverse cardiovascular events and an 89% increased risk of non-fatal heart attack — but there was no increased risk when calcium was taken with vitamin D [60]. A large European study found those using calcium-containing supplements were 86% more likely to have had a heart attack, and 139% more likely if using calcium-only supplements [61].

Stroke risk: A study of men and women aged 40–89 found that calcium supplementation at doses exceeding 1,000 mg/day doubled the risk of ischemic stroke, with men at 3 times the risk and women at 1.7 times the risk. No increased risk was seen at lower doses or when calcium was combined with vitamin D [62].

CVD mortality: A large 12-year study found that intakes of over 1,000 mg calcium from supplements were associated with a 20% increase in CVD mortality among men, but not women. However, total calcium intake (from all sources) up to approximately 1,200 mg/day was associated with decreased CVD mortality [63]. A 19-year Swedish study found women with intakes of 1,400 mg or more daily from diet were 40% more likely to die; if they also took 500 mg supplemental calcium, risk was 157% higher [64].

Coronary artery calcification: A 10-year study of 1,567 adults found that higher total dietary calcium was associated with lower calcification risk, but supplement use was associated with a 22% increase in calcification [65]. A meta-analysis of 9 trials (n=5,147) found 15% higher odds of calcification progression with supplement use [66]. Some researchers speculate that the acute spike in blood calcium following supplementation may promote arterial calcification, while calcium from food is absorbed more slowly [67].

Cholesterol effects in postmenopausal women: A 2-year study of Chinese women with high cholesterol found that postmenopausal women (ages 50–60) given 800 mg calcium (as carbonate) with supper experienced significant increases in total cholesterol and carotid artery thickness compared to placebo. No effect was seen in premenopausal women. The study used a single large dose rather than divided doses [68].

Blood pressure: A Cochrane Review of 16 trials (n=3,048) found that calcium supplementation (typically 1,000–2,000 mg/day) reduced systolic blood pressure by 1.43 mmHg and diastolic blood pressure by 0.98 mmHg, with greater effects in adults younger than 35 and at doses above 1,500 mg/day [69].

Cholesterol: A meta-analysis of 23 RCTs (n=4,071) found calcium supplements with or without vitamin D were associated with LDL cholesterol levels 4.6 mg/dL lower and HDL cholesterol levels 1.9 mg/dL higher [71].

Position statements: The National Osteoporosis Foundation and American Society for Preventive Cardiology concluded that calcium intakes within the UL (2,000–2,500 mg/day) are safe from a cardiovascular standpoint, finding no clear evidence that calcium from foods or supplements increases or decreases CVD risk [72]. However, some experts recommend that people with coronary artery disease avoid calcium supplementation without clinical recommendation and limit supplemental calcium to less than 500 mg if needed [66].

Aortic stenosis: A study of 2,657 elderly patients with aortic stenosis found that those supplementing with calcium (500–2,000 mg daily) with or without vitamin D were nearly 5 times as likely to require aortic valve replacement over 6 years [73].

Age-Related Macular Degeneration (AMD)

Evidence on calcium and AMD is mixed and comes from observational studies only. Higher dietary calcium (>1,247 mg/day) was associated with lower risk of late AMD in a 15-year study of over 2,000 adults [74]. Analysis of the AREDS study found that women over 65 with high supplemental calcium intake (~1,400 mg/day) had a 30% lower risk of neovascular ("wet") AMD [75]. However, another study found that adults over 67 taking more than 800 mg calcium from supplements were 164% more likely to be diagnosed with AMD [76].

Mortality

A study of white postmenopausal women found that calcium supplementation was associated with a 3.8% reduced risk of death over 22 years, but the benefit disappeared when more than 900 mg/day was taken from supplements [77]. A Canadian study found that up to 1,000 mg calcium from supplements was associated with a 22% reduced risk of death in women over 10 years, with no benefit in men or at higher doses [78].

Preeclampsia Prevention

A Cochrane Review of 27 RCTs (n=18,064) found that high-dose calcium supplementation (at least 1,000 mg/day) during pregnancy reduced the risk of preeclampsia by 64% in women with low dietary calcium intakes (<900 mg/day) [79]. An earlier meta-analysis of 10 RCTs (n=24,787) found a 38% overall reduction in preeclampsia risk with 1,500–2,000 mg/day calcium [80]. Several professional organizations recommend 1,500–2,000 mg calcium daily for pregnant women with low calcium intakes, including the WHO, ACOG, and the International Society for the Study of Hypertension in Pregnancy [79][80][81].

Weight Management

Early studies suggested calcium might aid weight loss, but subsequent evidence has been disappointing. A systematic review and meta-analysis of 41 RCTs found that higher calcium from dairy had no impact on body weight or body fat, except when combined with an energy-restricted diet. Calcium supplements had no effect on body weight or body fat [82]. However, WHI participants whose baseline calcium intake was less than 1,200 mg were 11% less likely to gain 1 kg or more when supplemented with calcium and vitamin D [83].

Metabolic Syndrome

An analysis of NHANES data (n=9,148 adults) found that women in the highest quintile of calcium intake (1,172+ mg/day) had a 27% lower risk of metabolic syndrome than those in the lowest quintile [84]. A meta-analysis of 10 studies (n=63,017) found a 7% drop in metabolic syndrome risk for each 300 mg/day increase in dietary calcium [85]. Clinical trial evidence is very limited.

Dementia

Despite an observational study finding calcium supplement users were nearly twice as likely to develop dementia (14% vs 8%) over 5 years [86], clinical trials have not confirmed this. A 5-year RCT of 1,460 older women found no increased risk of dementia-related hospitalizations or deaths with 1,200 mg calcium over 9.5 years of follow-up [87]. The WHI also found no increased dementia or mild cognitive impairment with calcium plus vitamin D supplementation over 8 years [88].

Dental Health

A randomized controlled trial found 60% lower odds of losing one or more teeth over three years in elderly participants taking 500–700 mg calcium plus 400–700 IU vitamin D compared to placebo [89]. This benefit likely stems from calcium's role in maintaining alveolar bone integrity.

PMS Symptom Reduction

1,200 mg of calcium per day from calcium carbonate has been found effective for reducing PMS symptoms in at least one substantial study [14].

Recommended Dosing

The recommended dietary allowances (RDAs) for calcium vary by age and sex, from the Institute of Medicine (now National Academy of Medicine) [1]:

Age Group	Male (mg/day)	Female (mg/day)	Pregnant	Lactating
0–6 months	200*	200*	—	—
7–12 months	260*	260*	—	—
1–3 years	700	700	—	—
4–8 years	1,000	1,000	—	—
9–18 years	1,300	1,300	1,300	1,300
19–50 years	1,000	1,000	1,000	1,000
51–70 years	1,000	1,200	—	—
71+ years	1,200	1,200	—	—

*Adequate Intake (AI). The RDA during pregnancy and lactation is not higher than for non-pregnant women because women's bodies increase calcium absorption efficiency during these periods [1][8].

Tolerable Upper Intake Level (UL)

Age Group	UL (mg/day)
0–6 months	1,000
7–12 months	1,500
1–8 years	2,500
9–18 years	3,000
19–50 years	2,500
51+ years	2,000

The UL includes calcium from all sources (food, supplements, antacids). The lower UL of 2,000 mg for adults over 50 reflects increased risk of kidney stones and cardiovascular events at higher intakes [1].

Practical Dosing Guidance

Dietary calcium should be factored in first. A cup of milk or yogurt provides 300–400 mg, a cup of cottage cheese about 138 mg. Most adults in the U.S. consume approximately 842 mg (women) to 1,083 mg (men) from food daily [2]. The general principle is food first, supplements to fill gaps — calculating average daily dietary calcium intake and supplementing only the difference needed to reach the RDA.

For supplementation:

• Limit individual doses to 500 mg or less for optimal absorption
• Take calcium carbonate with food; calcium citrate may be taken anytime
• Divide doses across the day rather than taking a single large dose
• Take calcium at least 2 hours apart from iron supplements and microminerals
• Take calcium at least 4 hours apart from levothyroxine (up to 6–8 hours if taking more than 500 mg calcium)

For specific conditions:

• Bone loss prevention (postmenopausal women): 1,000–1,200 mg/day total calcium (food + supplements) with 400–800 IU vitamin D [38]
• Building bone in adolescent girls (ages 9–13): 800 mg calcium with 400 IU vitamin D3 and 400 mg magnesium daily [32]
• Preeclampsia prevention (low-calcium pregnant women): 1,500–2,000 mg/day [79][80][81]
• PMS symptom reduction: 1,200 mg/day from calcium carbonate [14]

Antacids as Calcium Sources

Over-the-counter antacids like Tums contain calcium carbonate and can contribute substantially to daily intake. Even standard use can add over 1,000 mg of calcium per day. Tums Regular provides 200 mg calcium per tablet, with a maximum dose of 15 tablets/day (3,000 mg), far exceeding the UL [14].

Safety and Side Effects

Gastrointestinal Effects

Gas, bloating, and constipation are common, particularly with calcium carbonate. Calcium citrate tends to cause fewer GI symptoms. Taking supplements with meals or in divided doses can help reduce these effects [1].

Kidney Stones

Supplemental calcium (but not dietary calcium) is associated with approximately 17% increased kidney stone risk. The WHI trial showed that 1,000 mg supplemental calcium plus 400 IU vitamin D increased kidney stone incidence by 17% — though the absolute risk was small (0.35% vs 0.30%) [90]. Among postmenopausal women with kidney stone history, calcium supplement users had stones growing at 7.8 mm/month versus 4.49 mm/month in non-users [91]. Women with baseline 24-hour urine calcium above 132 mg had 15 times the risk of developing abnormally high urine calcium when given calcium supplementation [92]. Checking blood and urine calcium before and 3 months after starting supplementation is recommended for those at risk.

Paradoxically, dietary calcium is protective. A 5-year study of men with kidney stone history found that consuming 1,200 mg calcium daily from food (while restricting animal protein and salt) reduced stone recurrence by 63% compared to restricting calcium to 400 mg/day [93]. Dietary calcium binds oxalate in the gut, reducing its absorption and kidney stone risk.

Cardiovascular Risk

This is the most debated safety concern. A meta-analysis found a 30% increase in heart attack risk among adults taking calcium supplements, with no increased risk from dietary calcium [27]. A large Korean study found 54% increased risk of major cardiovascular events and 89% increased risk of non-fatal heart attack with calcium supplementation without vitamin D, though co-supplementation with vitamin D eliminated this risk [60]. Calcium at over 1,000 mg/day from supplements was associated with a doubling of ischemic stroke risk [62].

However, the National Osteoporosis Foundation and American Society for Preventive Cardiology concluded that calcium intakes not exceeding the UL are safe from a cardiovascular standpoint [72].

The Tolerable Upper Intake Level (UL) is 2,500 mg/day for ages 19–50 and 2,000 mg/day for ages 51+, including calcium from all sources.

Hypercalcemia

High-dose supplemental calcium can temporarily elevate blood calcium. A case report describes a 61-year-old man who developed mild hypercalcemia (11.1 mg/dL) after taking six Tums tablets (1,200 mg calcium) in a single evening [94]. A 62-year-old woman developed milk-alkali syndrome (hypercalcemia, metabolic acidosis, kidney damage) after taking 2,400 mg calcium from antacids daily plus 1,200 mg from a supplement for 6 weeks. Symptoms of milk-alkali syndrome include nausea, vomiting, headache, confusion, and fatigue, and can lead to kidney failure or death if untreated [95].

Other Concerns

• Prostate cancer: Some evidence links total calcium intake above 1,500 mg/day with increased risk [51]
• Early menopause: Supplemental calcium at 900 mg/day or more was associated with increased risk (not seen with dietary calcium) [96]
• Aortic stenosis: In patients with existing aortic stenosis, calcium supplementation was associated with nearly 5 times the risk of needing aortic valve replacement [73]
• Coronary calcification: Calcium supplement use was associated with 22% increased calcification risk, while higher total dietary calcium was protective [65]
• Dementia: Clinical trials have not shown increased dementia risk from calcium supplementation [87][88]
• Carotenoid absorption: 500 mg calcium carbonate taken with a meal reduced lycopene bioavailability by 83%. Carotenoid supplements or carotenoid-rich meals should be taken at a different time from calcium supplements [97]
• DXA scans: Partially dissolved calcium pills can interfere with DXA bone density scans within 30 minutes of ingestion. Do not take calcium supplements for 24 hours before a DXA scan [98]

Strontium in Bone Health Supplements

Some bone health supplements contain strontium. Due to its higher atomic weight than calcium, strontium can artificially inflate DXA-measured bone density by 8% or more at daily doses of 680 mg, and this effect persists months to years after discontinuation [99]. No research shows strontium citrate to be effective against osteoporosis. Strontium ranelate (a prescription drug not approved in the US or Canada, and no longer approved in Europe) has been linked to the severe drug reaction DRESS (drug reaction with eosinophilia and systemic symptoms) and cardiovascular risks [99][100].

Drug Interactions

Calcium supplements have numerous drug interactions and are the dietary supplement with the most potential interactions in older adults [101].

Calcium Reduces Drug Absorption

Drug Class	Examples	Separation Time	Mechanism
Levothyroxine	Synthroid, Levoxyl	4–6+ hours	Calcium carbonate, citrate, and acetate all reduce absorption by 20–25%. Liquid/softgel formulations may be less affected [102][103].
Fluoroquinolone antibiotics	Ciprofloxacin, levofloxacin, moxifloxacin	2h before or 6h after	Forms insoluble chelation complexes [1][14][104].
Tetracycline antibiotics	Doxycycline, minocycline	2h before or 2h after	Forms insoluble complexes [14][104].
Bisphosphonates	Alendronate (Fosamax), risedronate	30 min+ after bisphosphonate	Wait at least 30 minutes after taking bisphosphonate before calcium [105].
HIV integrase inhibitors	Dolutegravir (Tivicay, Dovato)	2h before or 6h after	Chelation substantially reduces dolutegravir blood levels [1][106].

Drugs That Affect Calcium Levels

Drug Class	Effect	Clinical Implication
Proton pump inhibitors (PPIs)	Impair absorption	Long-term PPIs may increase osteoporosis-related fracture risk. Switch to calcium citrate if using PPIs [14][19][21].
Thiazide diuretics	Increase calcium retention	Can increase risk of hypercalcemia and milk-alkali syndrome, especially if taking high-dose calcium supplements [14][107].
Lithium	Can cause hypercalcemia	Long-term lithium use can lead to hypercalcemia; concurrent calcium supplementation could increase this risk [1][108].

Other Interactions

• Iron: Calcium (particularly at doses of 300 mg or more) can impair iron absorption. Separate calcium supplements from iron supplements or iron-rich meals by at least 2 hours. This is especially important for those prone to iron deficiency [14].
• Aluminum-containing antacids (Maalox): Avoid calcium citrate specifically, as citrate increases aluminum absorption. People with kidney disease should be especially cautious [14][109].
• Micromineral interactions: Both calcium and magnesium supplements can interfere with absorption of trace minerals (iron, zinc, copper). Take trace mineral supplements at a different time of day from high-dose calcium or magnesium [14].
• Carotenoid supplements: 500 mg calcium carbonate reduced lycopene bioavailability by 83% from a meal. Separate carotenoid supplements from large calcium doses [97].

Dietary Sources

Dairy products provide approximately 72% of calcium intakes in the United States [1]. Nondairy sources include canned fish with bones, certain vegetables, and fortified foods.

Top Food Sources

Food	Serving	Calcium (mg)	% DV (1,300 mg)
Yogurt, plain, low fat	8 oz	415	32%
Orange juice, calcium-fortified	1 cup	349	27%
Mozzarella, part skim	1.5 oz	333	26%
Sardines, canned with bones	3 oz	325	25%
Milk, nonfat	1 cup	299	23%
Soymilk, calcium fortified	1 cup	299	23%
Milk, whole	1 cup	276	21%
Tofu, firm, with calcium sulfate	1/2 cup	253	19%
Salmon, canned with bones	3 oz	181	14%
Cottage cheese, 1%	1 cup	138	11%
Soybeans, cooked	1/2 cup	131	10%
Spinach, boiled	1/2 cup	123	9%
Kale, fresh, cooked	1 cup	94	7%
Chia seeds	1 tbsp	76	6%
Bok choy, raw, shredded	1 cup	74	6%
Broccoli, raw	1/2 cup	21	—

Source: USDA FoodData Central via NIH ODS [1][110].

Absorption from Food Sources

Absorption varies substantially by food type due to the presence of compounds that bind calcium:

• Dairy products and fortified foods: ~30–32% absorbed [1]
• Low-oxalate vegetables (broccoli, kale, cabbage): Absorption similar to milk (~27–30%), though the amount per serving is much lower [2]
• Soybeans: 31–41% absorbed, depending on phytate content [111]
• White beans: 22.5% absorbed [111]
• Red beans: 19.3% absorbed [111]
• Whole grain cereal: 17.0% absorbed [111]
• Rhubarb: ~9% absorbed (high oxalate) [111]
• Spinach: Only ~5% absorbed despite high calcium content (~123 mg per 1/2 cup cooked). Oxalate in spinach binds calcium, making it one of the worst food sources despite appearing calcium-rich [2][111]

Practical Notes

• Refining grains reduces calcium. White bread has less calcium than whole wheat bread, though whole grains also contain phytates that reduce absorption [1].
• Tap water averages ~12 mg per 8 oz glass (~7% of RDA from 6 glasses). Bottled mineral water provides ~49 mg per glass; spring water only ~5 mg. Reverse osmosis filtering removes nearly all calcium [14][112].
• Calcium-fortified foods (orange juice, almond milk, soy milk) are equivalent to calcium supplements, not whole food sources, since the calcium is added [14].
• Oxalates and phytates are "anti-nutrients" that bind calcium. Soaking beans may reduce phytate content. Cooking methods affect calcium retention [1][2][111].

Absorption varies significantly: approximately 32% from dairy, 27–41% from soybeans, 22–23% from beans, but only 5% from spinach due to high oxalate content [10].

References

1. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. 2011. Also: NIH Office of Dietary Supplements, "Calcium — Health Professional Fact Sheet." https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional/
2. Weaver CM, Heaney RP. "Calcium." In: Ross AC, et al., eds. Modern Nutrition in Health and Disease. 11th ed. Baltimore: Lippincott Williams & Wilkins; 2014:133–49.
3. Weaver CM. "Calcium." In: Marriott BP, et al., eds. Present Knowledge in Nutrition. 11th ed. Cambridge: Wiley-Blackwell; 2020:321–48.
4. Cano A, et al. "Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide." Maturitas. 2018;107:7–12. https://pubmed.ncbi.nlm.nih.gov/29169584/
5. Bailey RL et al., J Nutr, 2010. National Health and Nutrition Examination Survey analysis. https://pubmed.ncbi.nlm.nih.gov/24724766/
6. Blumberg JB, et al. "Contribution of dietary supplements to nutritional adequacy in race/ethnic population subgroups." Nutrients. 2017;9. https://pubmed.ncbi.nlm.nih.gov/29072669/
7. Marshall K, et al. "Inadequate calcium and vitamin D intake and osteoporosis risk in older Americans living in poverty." PLoS One. 2020;15:e0235042. https://pubmed.ncbi.nlm.nih.gov/32603341/
8. Grokipedia. "Calcium supplement." https://grokipedia.com/page/Calcium_supplement
9. Song L. "Calcium and bone metabolism indices." Adv Clin Chem. 2017;82:1–46. https://pubmed.ncbi.nlm.nih.gov/28939210/
10. Fong J, Khan A. "Hypocalcemia: updates in diagnosis and management for primary care." Can Fam Physician. 2012;58:158–62. https://pubmed.ncbi.nlm.nih.gov/22439169/
11. Bove-Fenderson E, Mannstadt M. "Hypocalcemic disorders." Best Pract Res Clin Endocrinol Metab. 2018;32:639–56. https://pubmed.ncbi.nlm.nih.gov/30449546/
12. Pepe J, et al. "Diagnosis and management of hypocalcemia." Endocrine. 2020;69:485–95. https://pubmed.ncbi.nlm.nih.gov/32451951/
13. Yang YX. "Calcium supplementation and risk of gastrointestinal side effects." Curr Gastroenterol Rep. 2012. https://pubmed.ncbi.nlm.nih.gov/22302267/
14. ConsumerLab. "Calcium and Bone Health Supplements Review." Accessed 2026. https://www.consumerlab.com/reviews/bone-supplements-calcium-with-vitamin-d-k-magnesium/calcium/
15. Sheikh MS, et al. "Gastrointestinal absorption of calcium from milk and calcium salts." N Engl J Med. 1987;317(9):532–6. https://pubmed.ncbi.nlm.nih.gov/3614303/
16. Reginster JY et al., Osteoporos Int, 1993.
17. Bristow SM et al., Br J Nutr, 2014. https://pubmed.ncbi.nlm.nih.gov/24933160/
18. Heaney RP, Dowell MS, Barger-Lux MJ. "Absorption of calcium as the carbonate and citrate salts." Osteoporos Int. 1999;9:19–23. https://pubmed.ncbi.nlm.nih.gov/10367025/
19. O'Connell MB et al., Am J Med, 2005. https://pubmed.ncbi.nlm.nih.gov/16164884/
20. Hansen KE et al., J Bone Miner Res, 2010. https://pubmed.ncbi.nlm.nih.gov/19874193/
21. Nafea OE, et al. "Calcium deficiency across different proton pump inhibitors." Cureus. 2026.
22. Hany M et al., Surg Obes Relat Dis, 2024.
23. Zhu M, et al. "Calcium and Magnesium Intakes and Cognitive Decline in Older Adults." J Alzheimers Dis. 2020;73(2):689–700. https://doi.org/10.3233/JAD-190745
24. Michalek JE, et al. "AlgaeCal and bone mineral density." Nutr J. 2011.
25. Kaats GR, et al. "AlgaeCal formulations and bone mineral density." Int J Med Sci. 2011.
26. Zenk JL, et al. "Aquamin vs calcium carbonate absorption." J Med Food. 2018.
27. Spencer H, et al. "Magnesium and calcium absorption interactions." J Am Coll Nutr. 1994.
28. Akhtar A, et al. "Dysphagia secondary to hypocalcemia and hypomagnesemia." Cureus. 2024.
29. Liu C, et al. "Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women." Food Funct. 2020;11:10817–27. https://pubmed.ncbi.nlm.nih.gov/33210697/
30. Reyes-Garcia R, et al. "Effects of daily intake of calcium and vitamin D-enriched milk in healthy postmenopausal women." J Womens Health. 2018;27:561–8. https://pubmed.ncbi.nlm.nih.gov/29106310/
31. Silk LN, et al. "The effect of calcium or calcium and vitamin D supplementation on bone mineral density in healthy males." Int J Sport Nutr Exerc Metab. 2015;25:510–24. https://pubmed.ncbi.nlm.nih.gov/25811308/
32. Greene DA, et al. "Calcium and vitamin D supplementation in young girls." Osteoporosis Int. 2011.
33. Manson JE, et al. "WHI calcium and vitamin D trial 20-year follow-up." JAMA. 2024.
34. Thomson CA, et al. "Long-Term Effect of Randomization to Calcium and Vitamin D Supplementation on Health in Older Women." Ann Intern Med. 2024;177(4):428–438. https://pubmed.ncbi.nlm.nih.gov/38467000/
35. Thorpe DL et al., Am J Clin Nutr, 2021. https://pubmed.ncbi.nlm.nih.gov/34134144/
36. Bailey RL, et al. "Calcium supplement use and bone fracture across the menopause transition." JBMR Plus. 2020;4:e10246. https://pubmed.ncbi.nlm.nih.gov/32025615/
37. Juliano S et al., BMJ, 2021.
38. Weaver CM, et al. "Calcium plus vitamin D supplementation and risk of fractures." Osteoporos Int. 2016;27:367–76. https://pubmed.ncbi.nlm.nih.gov/26510847/
39. Kahwati LC, et al. "Vitamin D, calcium, or combined supplementation for the primary prevention of fractures." JAMA. 2018;319:1600–12. https://pubmed.ncbi.nlm.nih.gov/29677308/
40. U.S. Preventive Services Task Force. "Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults." JAMA. 2018;319:1592–9. https://pubmed.ncbi.nlm.nih.gov/29677309/
41. Coombs C, et al. "Calcium supplementation before strenuous exercise and bone turnover." J Bone Miner Res. 2025.
42. Lappe J, et al. "Effect of vitamin D and calcium supplementation on cancer incidence in older women." JAMA. 2017;317:1234–43. https://pubmed.ncbi.nlm.nih.gov/28350929/
43. Brunner RL, et al. "The effect of calcium plus vitamin D on risk for invasive cancer: results of the WHI." Nutr Cancer. 2011;63:827–41. https://pubmed.ncbi.nlm.nih.gov/21774589/
44. Bristow SM, et al. "Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials." Br J Nutr. 2013;110:1384–93. https://pubmed.ncbi.nlm.nih.gov/23601861/
45. Lappe JM, et al. "Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial." Am J Clin Nutr. 2007;85:1586–91. https://pubmed.ncbi.nlm.nih.gov/17556697/
46. Keum N, et al. "Calcium intake and colorectal cancer risk: dose-response meta-analysis." Int J Cancer. 2014;135:1940–8. https://pubmed.ncbi.nlm.nih.gov/24623471/
47. Bonovas S, et al. "Calcium supplementation for the prevention of colorectal adenomas." World J Gastroenterol. 2016;22:4594–603. https://pubmed.ncbi.nlm.nih.gov/27182169/
48. Cauley JA, et al. "Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended." J Womens Health. 2013;22:915–29. https://pubmed.ncbi.nlm.nih.gov/24131320/
49. Crockett SD et al., Gut, 2018. https://pubmed.ncbi.nlm.nih.gov/28993399/
50. Kesse E, et al. "Dairy products, calcium and phosphorus intake, and the risk of prostate cancer." Br J Nutr. 2006;95:539–45. https://pubmed.ncbi.nlm.nih.gov/16512941/
51. Aune D, et al. "Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis." Am J Clin Nutr. 2015;101:87–117. https://pubmed.ncbi.nlm.nih.gov/25527754/
52. Baron JA, et al. "Calcium carbonate supplementation and prostate cancer risk." Cancer Epidemiol Biomarkers Prev. 2005.
53. Hidayat K, et al. "Calcium intake and breast cancer risk: meta-analysis." Br J Nutr. 2016;116:158–66. https://pubmed.ncbi.nlm.nih.gov/27169815/
54. Chlebowski RT, et al. "Calcium plus vitamin D supplementation and the risk of breast cancer." J Natl Cancer Inst. 2008;100:1581–91. https://pubmed.ncbi.nlm.nih.gov/19001601/
55. Song X, et al. "Calcium intake and the risk of ovarian cancer: a meta-analysis." Nutrients. 2017;9. https://pubmed.ncbi.nlm.nih.gov/28661458/
56. Yang B, et al. "Calcium intake and mortality from all causes, cancer, and cardiovascular disease." Am J Clin Nutr. 2016;103:886–94. https://pubmed.ncbi.nlm.nih.gov/26864357/
57. Asemi Z, et al. "Total, dietary, and supplemental calcium intake and mortality from all-causes." Nutr Metab Cardiovasc Dis. 2015;25:623–34. https://pubmed.ncbi.nlm.nih.gov/25887729/
58. Bolland MJ, et al. "Effect of calcium supplements on risk of myocardial infarction and cardiovascular events." BMJ. 2010;341:c3691. https://pubmed.ncbi.nlm.nih.gov/20671013/
59. Bolland MJ, et al. "Calcium supplements with or without vitamin D and risk of cardiovascular events." BMJ. 2011;342:d2040. https://doi.org/10.1136/bmj.d2040
60. Kim KJ et al., Eur Heart J Cardiovasc Pharmacother, 2021.
61. Li K et al., Heart, 2012.
62. de Abajo FJ et al., J Am Heart Assoc, 2017.
63. Xiao Q et al., JAMA Intern Med, 2013. https://pubmed.ncbi.nlm.nih.gov/23381719/
64. Michaelsson K, et al. "Long-term calcium intake and death rate in women." BMJ. 2013.
65. Anderson JJ, et al. "Calcium intake from diet and supplements and the risk of coronary artery calcification." J Am Heart Assoc. 2016;5. https://pubmed.ncbi.nlm.nih.gov/27729333/
66. Bazarbashi N, et al. "Calcium supplementation and coronary artery calcification progression." JACC Cardiovasc Imaging. 2020. Also: Michos ED, et al. "Calcium supplementation in coronary artery disease." JACC Cardiovasc Imaging. 2021.
67. Reid IR, et al. "Calcium supplements and cardiovascular disease." Heart. 2012.
68. Li S, et al. "Calcium supplementation, cholesterol, and carotid artery thickness in postmenopausal women." Am J Clin Nutr. 2013.
69. Cormick G, et al. "Calcium supplementation for prevention of primary hypertension." Cochrane Database Syst Rev. 2015. https://pubmed.ncbi.nlm.nih.gov/26106476/
70. Champagne CM. "Dietary interventions on blood pressure: the DASH trials." Nutr Rev. 2006;64:S53–6. https://pubmed.ncbi.nlm.nih.gov/16770951/
71. Chen C, et al. "The effects of dietary calcium supplements alone or with vitamin D on cholesterol metabolism." J Cardiovasc Nurs. 2017;32:496–506. https://pubmed.ncbi.nlm.nih.gov/27828914/
72. Kopecky SL, et al. "Lack of evidence linking calcium with or without vitamin D supplementation to cardiovascular disease." Ann Intern Med. 2016;165:867–8. https://pubmed.ncbi.nlm.nih.gov/27776362/
73. Kassis N, et al. "Calcium supplementation and aortic valve replacement risk in aortic stenosis." Heart. 2022.
74. Gopinath B, et al. "Dietary calcium and age-related macular degeneration." Br J Nutr. 2014.
75. Tisdale AK, et al. "Calcium supplementation and AMD risk in women." JAMA Ophthalmol. 2019.
76. Kakigi CL, et al. "Calcium supplement use and AMD risk." JAMA Ophthalmol. 2015.
77. Mursu J, et al. "Calcium supplementation and all-cause mortality." Arch Intern Med. 2011.
78. Langsetmo L et al., J Clin Endocrinol Metab, 2013. https://pubmed.ncbi.nlm.nih.gov/23426618/
79. Hofmeyr GJ, et al. "Calcium supplementation during pregnancy for preventing hypertensive disorders." Cochrane Database Syst Rev. 2018. https://pubmed.ncbi.nlm.nih.gov/30277579/
80. Tang R, et al. "Limited evidence for calcium supplementation in preeclampsia prevention: a meta-analysis." Hypertens Pregnancy. 2015;34:181–203. https://pubmed.ncbi.nlm.nih.gov/25699244/
81. American College of Obstetricians and Gynecologists. "Hypertension in Pregnancy." Obstet Gynecol. 2013;122:1122–31. Also: WHO. Guideline: Calcium Supplementation in Pregnant Women. Geneva: WHO; 2013.
82. Systematic review and meta-analysis of 41 RCTs of dairy foods or calcium supplements in 4,802 adults, per NIH ODS [1].
83. WHI substudy on calcium, vitamin D, and weight gain in postmenopausal women, per NIH ODS [1].
84. NHANES analysis of calcium intake and metabolic syndrome in 9,148 adults, per NIH ODS [1].
85. Meta-analysis of 10 studies (n=63,017) on calcium and metabolic syndrome, per NIH ODS [1].
86. Kern J, et al. "Calcium supplementation and dementia risk in Swedish women." Neurology. 2016.
87. Ghasemifard S et al., Lancet Reg Health West Pac, 2025.
88. Rossom RC et al., J Am Geriatr Soc, 2012.
89. Calcium and vitamin D supplementation and tooth loss in the elderly (RCT), per Grokipedia [8].
90. Wallace RB et al., Am J Clin Nutr, 2011. https://pubmed.ncbi.nlm.nih.gov/21068346/
91. Loftus CJ, et al. "Calcium supplements and kidney stone growth rate." J Am Soc Nephrol (Abstract). 2015.
92. Gallagher JC et al., Menopause, 2014.
93. Borghi L et al., N Engl J Med, 2002. https://pubmed.ncbi.nlm.nih.gov/11794170/
94. Cimpeanu E, et al. "Hypercalcemia from TUMS." SAGE Open Med Case Rep. 2020.
95. Opoku B, et al. "Milk-alkali syndrome from calcium supplements." Cureus. 2023.
96. Purdue-Smithe AC et al., Am J Clin Nutr, 2017.
97. Borel P et al., Br J Nutr, 2017.
98. Krueger D, et al. "Calcium pills interfere with DXA scans." J Clin Densitom. 2006.
99. Mirza F, et al. "Strontium and DXA bone density overestimation." J Nutr Health Food Sci. 2016. Also: Williams AJ, et al. "Strontium and falsely elevated calcium in blood tests." J Appl Lab Med. 2023.
100. Kolitz E, et al. "DRESS reaction from strontium citrate supplement." JAAD Case Rep. 2021. Also: European Medicines Agency. Strontium ranelate withdrawal. 2020.
101. de Leon J, et al. "Dietary supplement-medication interactions in older adults." J Nutr Gerontol Geriatr. 2018.
102. Zamfirescu I et al., Thyroid, 2011. Also: Morini E et al., Endocrine, 2018.
103. Liu H, et al. Ther Clin Risk Manag. 2023; Gatta B, et al. Front Endocrinol. 2022.
104. Pletz MW et al., Antimicrob Agents Chemother, 2003; Neuvonen PJ et al., Drugs, 1976.
105. Fosamax (Alendronate) Prescribing Information. 2012.
106. FDA-approved prescribing information for dolutegravir (Dovato, Tivicay).
107. Hakim R et al., Can Med Assoc J, 1979.
108. NIH ODS. "Lithium and calcium interactions." Per [1].
109. Coburn JW et al., Am J Kidney Dis, 1991.
110. U.S. Department of Agriculture. FoodData Central. 2021.
111. Brogren M et al., Asia Pac J Clin Nutr, 2003; Heaney RP et al., Am J Clin Nutr, 1988; Shkembi B et al., Nutrients, 2022.
112. Moor S, et al. "Calcium in drinking water." HSS J. 2006. Also: Kamalapriya M, et al. "Reverse osmosis and calcium removal." Cureus. 2023.